New patent expiration for Astrazeneca Ab drug FARXIGA
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. […]
New patent expiration for Astrazeneca Ab drug FARXIGA Read Post »
Patent Expiration
New patent expiration for Astrazeneca Ab drug QTERN
Annual Drug Patent Expirations for QTERN Qtern is a drug marketed by Astrazeneca Ab and is included in two NDAs.
New patent expiration for Astrazeneca Ab drug QTERN Read Post »
Drug Patent Expirations for the Week of October 4, 2020
BYDUREON (exenatide synthetic) Astrazeneca ab Patent: 9,198,925 Expiration: Oct 4, 2020 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of October 4, 2020 Read Post »
New patent expiration for Astrazeneca Ab drug BYDUREON
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs.
New patent expiration for Astrazeneca Ab drug BYDUREON Read Post »
New patent expiration for Astrazeneca Ab drug BYDUREON PEN
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one
New patent expiration for Astrazeneca Ab drug BYDUREON PEN Read Post »
New patent expiration for Astrazeneca Ab drug BYDUREON BCISE
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one
New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Read Post »
New patent expiration for Astrazeneca Ab drug QTERNMET XR
Annual Drug Patent Expirations for QTERNMET+XR Qternmet Xr is a drug marketed by Astrazeneca Ab and is included in one
New patent expiration for Astrazeneca Ab drug QTERNMET XR Read Post »
New patent expiration for Boehringer Ingelheim drug OFEV
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA.
New patent expiration for Boehringer Ingelheim drug OFEV Read Post »
New patent expiration for Novartis drug TYKERB
Annual Drug Patent Expirations for TYKERB Tykerb is a drug marketed by Novartis and is included in one NDA. It
